NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Stanley T Crooke
Ionis Pharmaceuticals - Carlsbad / United States
Medical and Health Sciences / Biochemistry
AD Scientific Index ID: 4465400
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Stanley T Crooke's MOST POPULAR ARTICLES
1-)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised …FJ Raal, RD Santos, DJ Blom, AD Marais, MJ Charng, WC Cromwell, ...The Lancet 375 (9719), 998-1006, 20109622010
2-)
Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents: a comparative analysisTA Vickers, S Koo, CF Bennett, ST Crooke, NM Dean, BF BakerJournal of Biological Chemistry 278 (9), 7108-7118, 20037542003
3-)
RNA-targeted therapeuticsST Crooke, JL Witztum, CF Bennett, BF BakerCell metabolism 27 (4), 714-739, 20187462018
4-)
Antisense oligonucleotides targeting apolipoprotein (a) in people with raised lipoprotein (a): two randomised, double-blind, placebo-controlled, dose-ranging trialsNJ Viney, JC van Capelleveen, RS Geary, S Xia, JA Tami, ZY Rosie, ...The Lancet 388 (10057), 2239-2253, 20167452016
5-)
Progress in antisense technologyST CrookeAnnu. Rev. Med. 55 (1), 61-95, 20047172004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept